Felicity Smith1. 1. Department of Practice and Policy, School of Pharmacy, University of London, Mezzanine Floor, BMA House, Tavistock Square, London, WC1H 9JP, UK. felicity.smith@pharmacy.ac.uk
Abstract
AIM OF THE REVIEW: In low and middle income countries private pharmacies are considered a valuable resource for health advice and medicines in many communities. However the quality of the service they provide has often been questioned and is unclear. This paper reviews the evidence regarding the quality of professional services from private pharmacies in low and middle-income countries. METHOD: A literature search (computer and hand searches) was undertaken to identify all studies which included an assessment of the quality of some aspect of private pharmacy services in low and middle income countries. RESULTS: 30 studies were identified which spanned all regions in the developing world. These included 9 which examined the scope and/or quality of a range of professional services, 14 which assessed the quality of advice provided in response to specific symptoms and 7 which investigated the supply of medicines without a prescription. A range of methods were employed, in particular, questionnaire surveys with staff and/or clients and assessment of practice using simulated client methodology. Whilst many authors identified a potential for pharmacies to contribute more effectively to primary health care, virtually all studies identified deficiencies in the quality of current professional practice. In particular authors highlighted the lack of presence of pharmacists or other trained personnel, the provision of advice for common symptoms which was not in accordance with guidelines and the inappropriate supply of medicines. CONCLUSION: The evidence-base regarding the quality of professional services from pharmacies in low and middle income countries is limited, but indicates that standards are often deficient. If pharmacists are to contribute effectively to health care, the barriers to the provision of higher quality care and ways in which these might be overcome must be identified and examined.
AIM OF THE REVIEW: In low and middle income countries private pharmacies are considered a valuable resource for health advice and medicines in many communities. However the quality of the service they provide has often been questioned and is unclear. This paper reviews the evidence regarding the quality of professional services from private pharmacies in low and middle-income countries. METHOD: A literature search (computer and hand searches) was undertaken to identify all studies which included an assessment of the quality of some aspect of private pharmacy services in low and middle income countries. RESULTS: 30 studies were identified which spanned all regions in the developing world. These included 9 which examined the scope and/or quality of a range of professional services, 14 which assessed the quality of advice provided in response to specific symptoms and 7 which investigated the supply of medicines without a prescription. A range of methods were employed, in particular, questionnaire surveys with staff and/or clients and assessment of practice using simulated client methodology. Whilst many authors identified a potential for pharmacies to contribute more effectively to primary health care, virtually all studies identified deficiencies in the quality of current professional practice. In particular authors highlighted the lack of presence of pharmacists or other trained personnel, the provision of advice for common symptoms which was not in accordance with guidelines and the inappropriate supply of medicines. CONCLUSION: The evidence-base regarding the quality of professional services from pharmacies in low and middle income countries is limited, but indicates that standards are often deficient. If pharmacists are to contribute effectively to health care, the barriers to the provision of higher quality care and ways in which these might be overcome must be identified and examined.
Authors: Mauro Cunha Ramos; Rodrigo D Correa da Silva; Ricardo O Gobbato; Felipe Civeira da Rocha; Giusepe de Lucca Júnior; Jacques Vissoky; Tania Cestari; Absalom Filgueiras Journal: Int J STD AIDS Date: 2004-05 Impact factor: 1.359
Authors: Miguel A Gastelurrutia; S I Charlie Benrimoj; Carla C Castrillon; María J Casado de Amezua; Fernando Fernandez-Llimos; Maria J Faus Journal: Pharm World Sci Date: 2008-11-08
Authors: N Nyazema; N Viberg; S Khoza; S Vyas; L Kumaranayake; G Tomson; C Stålsby Lundborg Journal: J Antimicrob Chemother Date: 2007-03-02 Impact factor: 5.790
Authors: Catherine Goodman; William Brieger; Alasdair Unwin; Anne Mills; Sylvia Meek; George Greer Journal: Am J Trop Med Hyg Date: 2007-12 Impact factor: 2.345
Authors: Amita Gupta; Suvarna S Sane; Ajay Gurbani; Robert C Bollinger; Sanjay M Mehendale; Sheela V Godbole Journal: BMC Public Health Date: 2010-08-27 Impact factor: 3.295
Authors: Raja'a A Al-Qudah; Rana Abu Farha; Maram M Al Ali; Nour S Jaradaneh; Mohamed Izham Mohamed Ibrahim Journal: J Pharm Bioallied Sci Date: 2021-05-26